最新报道:MEI Pharma (MEIP) shares surged 21% following the biotech firm's unprecedented move to convert its entire treasury into cryptocurrency, signaling a bold shift in corporate finance strategy. The company, known for its oncology-focused therapeutics, announced the decision as part of a broader initiative to embrace blockchain technology for financial operations. While specific cryptocurrencies were not disclosed, MEI Pharma emphasized its commitment to leveraging digital assets for treasury management. Analysts speculate this could set a precedent for other biotech firms exploring crypto adoption. The market reaction highlights growing investor interest in traditional sectors integrating Web3 solutions.